EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease

Yufang Yao iD, Zhiyue Zhao, Fubo Zhang, Na Miao, Nan Wang, Xin Xu, Chaoping Yang

Brain and Behavior · 2023-03 · 13 (3)

DOI: 10.1002/brb3.2921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 16.02.2023. Verfasst von Yufang Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department 7 of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Self-funded Project of Cangzhou Key Plan in 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is one of the most common systemic neurodegenerative diseases and is related to the loss of dopaminergic neurons in the substantia nigra. Several studies verified that microRNA (miRNAs) targeting the Bim/Bax/caspase‐3 signaling axis is involved in the apoptosis of dopaminergic neurons in substantia nigra. In this study, we aimed to explore the role of miR‐221 in PD.

Methods

To examine the function of miR‐221 in vivo, we used a well‐established 6‐OHDA‐induced PD mouse model. Then we conducted adenovirus‐mediated miR‐221 overexpression in the PD mice.

Results

Our results showed that miR‐221 overexpression improved motor behavior of the PD mice. We demonstrated that overexpression of miR‐221 reduced the loss of dopaminergic neurons in the substantia nigra striatum by promoting their antioxidative and antiapoptosis capacities. Mechanistically, miR‐221 targets Bim, thus inhibiting Bim and Bax caspase‐3 mediated apoptosis signaling pathways.

Conclusion

Our findings suggest miR‐221 participates in the pathological process of PD and might be a potential drug target and provide new insight into PD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMicroRNAsMiceAnimalsDopaminergic NeuronsCaspase 3bcl-2-Associated X ProteinApoptosisSubstantia NigraMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

Bax/caspase-3 signalingBimMiR-221Parkinson's disease

Substanzen

Caspase 3bcl-2-Associated X ProteinMicroRNAsMIRN221 microRNA, mouse

Autor:innen und Institutionen

  • Department 7 of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
  • College of Mechanical and Electrical Engineering, Cangzhou Normal University, Cangzhou, Hebei, China.
  • Department 4 of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
  • Department 1 of Traditional Chinese Medicine, Cangzhou Central Hospital, Cangzhou, Hebei, China.

ORCID-Profile: Yufang Yao

Förderung

  • Self-funded Project of Cangzhou Key Plan in 2020

Zitieren

APA

Yao, Y., Zhao, Z., Zhang, F., Miao, N., Wang, N., Xu, X., & Yang, C. (2023). microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease. Brain and Behavior, 13(3). https://doi.org/10.1002/brb3.2921

Vancouver

Yao Y, Zhao Z, Zhang F, Miao N, Wang N, Xu X, et al. microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease. Brain and Behavior. 2023;13(3). doi:10.1002/brb3.2921

BibTeX
@article{Yao2023,
  author = {Yao, Yufang and Zhao, Zhiyue and Zhang, Fubo and Miao, Na and Wang, Nan and Xu, Xin and Yang, Chaoping},
  title = {microRNA‐221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease},
  journal = {Brain and Behavior},
  year = {2023},
  volume = {13},
  number = {3},
  doi = {10.1002/brb3.2921}
}
Kostenlos starten →